Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Amundi on the deal. Amundi Asset Management SAS finalized its €149 million strategic acquisition of aixigo AG, a technology company that has developed...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised BNP Paribas on the deal. BNP Paribas has signed an agreement with HSBC for the acquisition of their Private Banking activities in Germany,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Onex Corporation on the deal. Onex Corporation (TSX: ONEX) announced that Onex Partners Opportunities Fund has agreed to make a majority investment in...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised investment firm 3i Group plc on the sale of nexeye to KKR advised by Kirkland & Ellis. KKR has acquired Gorinchem-headquartered nexeye from...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised International Chemical Investors Group (ICIG). International Chemical Investors Group (ICIG) took over the entire division with around 1,000 employees and superabsorber production facilities in...
You must be a Standard 1 Year member to access this content.
Ashurst advised Commerzbank AG on the deal. Clifford Chance advised Aquila Group. Commerzbank AG accelerated its growth in the sustainability business by acquiring a majority stake in...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Paragon Partners and the minority shareholders. Taylor Wessing advised International Chemical Investors Group. Paragon Partners and the minority shareholders have announced the sale...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Oldenburgische Landesbank on the deal. Oldenburgische Landesbank (OLB) on its acquisition of Degussa Bank AG. The parties agreed a purchase price of EUR...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm Group on the deal. Neuraxpharm Group acquired two portfolios of established products from Sanofi which are marketed globally in more than...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Gilde Buy Out Partners, Taylor Wessing advised ]init[ AG and Noerr advised EMERAM Capital. Shearman & Sterling advised the shareholders of ]init[....
You must be a Standard 1 Year member to access this content.
IN BRIEF: Clifford Chance, Noerr, Taylor Wessing, advised on the matter. Clifford Chance advised Gilde Buy Out Partners with a team including Ines Keitel (Employment), Claudia...
You must be a Standard 1 Year member to access this content.
